NO20064007L - Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover - Google Patents
Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnoverInfo
- Publication number
- NO20064007L NO20064007L NO20064007A NO20064007A NO20064007L NO 20064007 L NO20064007 L NO 20064007L NO 20064007 A NO20064007 A NO 20064007A NO 20064007 A NO20064007 A NO 20064007A NO 20064007 L NO20064007 L NO 20064007L
- Authority
- NO
- Norway
- Prior art keywords
- preventing
- individuals
- bone turnover
- procedure
- treating osteoporosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/783,092 US20050187302A1 (en) | 2004-02-23 | 2004-02-23 | Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
PCT/FI2005/000034 WO2005079776A1 (fr) | 2004-02-23 | 2005-01-19 | Procede de traitement ou de prevention de l'osteoporose chez des individus presentant un renouvellement des cellules osseuses eleve |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064007L true NO20064007L (no) | 2006-09-21 |
Family
ID=34861145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064007A NO20064007L (no) | 2004-02-23 | 2006-09-06 | Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050187302A1 (fr) |
EP (1) | EP1718287A1 (fr) |
JP (1) | JP2007523209A (fr) |
CN (1) | CN1972680A (fr) |
AU (1) | AU2005215173A1 (fr) |
BR (1) | BRPI0507912A (fr) |
CA (1) | CA2557116A1 (fr) |
MX (1) | MXPA06009549A (fr) |
NO (1) | NO20064007L (fr) |
RU (1) | RU2006133903A (fr) |
WO (1) | WO2005079776A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
US20080171319A1 (en) * | 2006-02-06 | 2008-07-17 | Mickey Urdea | Osteoporosis associated markers and methods of use thereof |
ES2524002T3 (es) * | 2007-02-14 | 2014-12-03 | Forendo Pharma Ltd. | Método para la preparación de derivados de trifenilbuteno con valor terapéutico |
WO2008099060A2 (fr) * | 2007-02-14 | 2008-08-21 | Hormos Medical Ltd | Procédés de préparation de fispémifène à partir d'ospémifène |
JP5010034B2 (ja) * | 2007-12-28 | 2012-08-29 | エフ.ホフマン−ラ ロシュ アーゲー | 生理学的状態の評価 |
CN102690347B (zh) * | 2012-05-18 | 2014-06-25 | 北京北方生物技术研究所 | 分离i型前胶原氨基末端肽的方法 |
JP6174156B2 (ja) | 2012-10-19 | 2017-08-02 | フェルミオン オサケ ユキチュア | オスペミフェンの製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9418067D0 (en) * | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
-
2004
- 2004-02-23 US US10/783,092 patent/US20050187302A1/en not_active Abandoned
-
2005
- 2005-01-19 EP EP05708122A patent/EP1718287A1/fr not_active Ceased
- 2005-01-19 MX MXPA06009549A patent/MXPA06009549A/es unknown
- 2005-01-19 RU RU2006133903/14A patent/RU2006133903A/ru not_active Application Discontinuation
- 2005-01-19 AU AU2005215173A patent/AU2005215173A1/en not_active Abandoned
- 2005-01-19 JP JP2007500232A patent/JP2007523209A/ja not_active Abandoned
- 2005-01-19 WO PCT/FI2005/000034 patent/WO2005079776A1/fr active Application Filing
- 2005-01-19 CA CA002557116A patent/CA2557116A1/fr not_active Abandoned
- 2005-01-19 CN CNA2005800049712A patent/CN1972680A/zh active Pending
- 2005-01-19 BR BRPI0507912-8A patent/BRPI0507912A/pt not_active IP Right Cessation
-
2006
- 2006-09-06 NO NO20064007A patent/NO20064007L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0507912A (pt) | 2007-07-10 |
MXPA06009549A (es) | 2007-04-10 |
CN1972680A (zh) | 2007-05-30 |
CA2557116A1 (fr) | 2005-09-01 |
EP1718287A1 (fr) | 2006-11-08 |
WO2005079776A1 (fr) | 2005-09-01 |
JP2007523209A (ja) | 2007-08-16 |
RU2006133903A (ru) | 2008-03-27 |
AU2005215173A1 (en) | 2005-09-01 |
US20050187302A1 (en) | 2005-08-25 |
AU2005215173A8 (en) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064007L (no) | Fremgangsmate for forhinding eller behandling av osteoporose i individer med hoy ben turnover | |
TWI349851B (en) | Processor,computing system and method of managing power | |
NO20072863L (no) | Fremgangsmate til a rense FSH | |
NO20072352L (no) | Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet | |
DK1778234T4 (da) | Pimobendan til anvendelse til reduceringen af hjertestørrelse i pattedyr som lider af hjertesvigt | |
TWI315825B (en) | Computing platform and method to execute independently of an operating system | |
GEP20094714B (en) | Method and architecture for accessing an internet protocol multimedia subsystem (ims) over a wireless local area network (wlan) | |
TW200627594A (en) | A method to form a passivation layer | |
NO20070910L (no) | Pyrrolderivater som farmasoytiske middel | |
NO20092612L (no) | Forbindelser og metode for kinasemodulering og indikasjoner for dette | |
TWI263271B (en) | Method for enhancing fluorine utilization | |
DK2415864T3 (da) | Oligomerase-2-enzymer (eller beta-xylosidaseenzymer), nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem | |
TW200602324A (en) | Tetrahydro-indazole cannabinoid modulators cross reference to related applications | |
MY148863A (en) | Hexahydro-cyclooctyl pyrazole cannabinoid modulators | |
NO20084567L (no) | Polymorfe former av (2S) - (4E) -N-metyl-5-(3-isopropoksypyridin)yl]-4-penten-2-amin for behandling av sykdommer i sentralnervesystemet | |
GB2464247A (en) | Method and system for dynamic call anchoring | |
NO20092073L (no) | Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav | |
NO20055187L (no) | Fremgangsmate for behandling og forebygging av lavere urinkanal symptomer | |
GB0525250D0 (en) | Telephone system,switching system and management method of telephone system | |
IS8650A (is) | Aðferð og kerfi til að draga úr eldsneytisnotkun dísilvélar. | |
NO20051432D0 (no) | Komposittplate for ortopediteknikken, fremgangsmate til dens fremstilling og dens anvendelse | |
AU2003283217A8 (en) | Method for determing predisposition to manifestation of immune system related diseases | |
AU2003237543A1 (en) | Double side igbt phase leg architecture and clocking method for reduced turn on loss | |
IL190347A0 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
NO20053156L (no) | Anvendelse av ostrogen reseptor alfa modulatorer for behandling av multippel sklerose. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |